Open A New Era
Company Overview

Shanghai EGT Synbio Group Co., Ltd.

Founded in 2016 in Minhang, Shanghai, Shanghai EGT Synbio Group Co., Ltd. is a science-driven company developing cellular anti-aging active ingredients through synthetic bio-manufacturing. Built on three core platforms — active-molecule discovery, bio-manufacturing with ultra-purification, and intelligent delivery — the company covers the full chain from molecule discovery to green manufacturing and purification, delivery and branded-ingredient enablement, with the goal of becoming a global leader in ergothioneine and other natural anti-aging ingredients.

Technical Strength

Built on a synthetic-biology R&D platform, the company continuously optimizes strain construction, directed enzyme evolution, fermentation scale-up, purification-crystallization and quality testing, and supports stable production and application development with a complete set of qualifications and IP.

  • Team

    2 PhDs, 5 master is holders and a 10-person core research team drawn from the Chinese Academy of Sciences and Shanghai universities.

  • Capacity

    large-scale fermenters; hundred-tonne annual capacity; stable output of 99.99% ergothioneine.

  • Company

    founded 2016, Minhang (Shanghai), 2,000 m² of R&D space.

  • Scientific Advisory Board

    senior professors and PhDs, incl. SIOC (Chinese Academy of Sciences).

  • Technology

    directed-evolution fermentation + synthetic biology; 99.99% purity; optical rotation +124°; heavy metals <10 ppm; non-toxic, no residues.

  • Certifications

    U.S. FDA GRAS (GRN 1191), GMP; NSF, ISO 9001/22000, HALAL, KOSHER].

  • IP & standards

    26 patents filed/granted; 10 SCI papers; led/participated in group standard T/CEAC 036-2024 "Ergothioneine".

  • Quality record

    600+ batches delivered with zero quality complaints.

Project Development History

From a seed to a towering tree, every step we take is down-to-earth, moving towards a farther future.

Project launch (2016)

to overcome solvent/toxic-impurity residues of chemical synthesis and the high cost of mushroom extraction, the company formed an R&D team and began green fermentation of ergothioneine.

R&D (2016–2020)

through strain screening, fermentation design, process optimization and purification improvements, the company achieved stable production of 99.99%-purity ergothioneine by green fermentation.

Scale-up (2021)

a fully automated fermentation line enabled stable mass production at 99.99% purity, +124° optical rotation and <10 ppm total heavy metals, via enzymatic directed fermentation — true green production.

International recognition (2024–2025)

Dr.Ergo® ergothioneine obtained U.S. FDA GRAS status (GRN 1191); NSF certification and the group standard T/CEAC 036-2024.